Indaptus Therapeutics, Inc. Shares Outstanding (Cover Page)
Indaptus Therapeutics, Inc. (INDP) had Shares Outstanding (Cover Page) of 133.24 million shares as of 2026-08-13, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-13: Entity Common Stock, Shares Outstanding 133.24M shares.
- 2026-05-15: Entity Common Stock, Shares Outstanding 113.24M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 2.24M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 1.75M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 133.24M shares 10-Q · filed 2026-08-13 |
| 2026-05-15 | 113.24M shares 10-Q · filed 2026-05-15 |
| 2026-03-16 | 2.24M shares 10-K · filed 2026-03-17 |
| 2025-11-11 | 1.75M shares 10-Q · filed 2025-11-12 |
| 2025-08-12 | 1.11M shares 10-Q · filed 2025-08-13 |
| 2025-05-12 | 16.03M shares 10-Q · filed 2025-05-14 |
| 2025-03-12 | 14.43M shares 10-K · filed 2025-03-13 |
| 2024-11-11 | 10.20M shares 10-Q · filed 2024-11-12 |
| 2024-08-09 | 10.20M shares 10-Q · filed 2024-08-12 |
| 2024-05-07 | 8.54M shares 10-Q · filed 2024-05-08 |
| 2024-03-12 | 8.54M shares 10-K · filed 2024-03-13 |
| 2023-11-03 | 8.40M shares 10-Q · filed 2023-11-06 |
| 2023-08-11 | 8.40M shares 10-Q · filed 2023-08-14 |
| 2023-05-11 | 8.40M shares 10-Q · filed 2023-05-11 |
| 2023-03-17 | 8.40M shares 10-K · filed 2023-03-17 |
| 2022-11-09 | 8.26M shares 10-Q · filed 2022-11-10 |
| 2022-08-04 | 8.26M shares 10-Q · filed 2022-08-08 |
| 2022-05-10 | 8.26M shares 10-Q · filed 2022-05-12 |
| 2022-03-16 | 8.26M shares 10-K · filed 2022-03-21 |
| 2021-11-11 | 8.19M shares 10-Q · filed 2021-11-15 |
| 2021-08-12 | 5.41B shares 10-Q · filed 2021-08-16 |
| 2021-06-25 | 100.00 shares 10-Q · filed 2021-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |